Speaker illustration

Mr Ao Chen

Zhongshan Hospital, Fudan University, Shanghai (China)

Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome-dependent pyroptosis

Event: ESC Congress 2020

Topic: Inflammation

Session: Thrombosis and Inflammation in Acute Coronary Syndrome: Insights from Translational Research

Thumbnail

Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells

Event: ESC Congress 2018

Topic: Inflammation and Immunity

Session: Inflammation and immunity in acute coronary syndromes

Thumbnail

Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome-dependent pyroptosis

Event: ESC Asia with APSC & AFC 2020

Topic: Inflammation

Session: Abstract Programme

Thumbnail

ESC 365 is supported by

logo Novo Nordisk